However, compared with C-axSpAnd, patients were not selected for elevated MRI and/or CRP; eligible patients were required to have inflammatory back pain, with approximately 30% presenting with radiographic sacroiliitis meeting mNY classification criteria at baseline [31]. This evidence concerns the gene CRP and Sacroiliac arthritis.